Share the post "FERMENTA BIOTECH announces Q1 Report: Revenue Dropped by 5.23% YoY"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -5.23 % over the year, decrease in net sales/revenue by -19.73 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 40.41 %. Marginal decrease of -40.98% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for FERMENTA BIOTECH LIMITED. Profit dropped by -368.34 % Year to Year, FERMENTA BIOTECH LIMITED’s profitability dropped by -16.95 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -414.06 % Year to Year. EPS decreased by -16.6 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 82.448 Cr | Rs. 97.339 Cr | Rs. 78.132 Cr | -19.73 % | -5.23 % |
Expenses | Rs. 71.52 Cr | Rs. 91.36 Cr | Rs. 77.33 Cr | -15.36 % | + 8.12 % |
Operating Profit | Rs. 10.93 Cr | Rs. 5.98 Cr | Rs. 0.8 Cr | -86.62 % | -92.68 % |
OPM % | 13.26 % | 6.14 % | 1.02 % | -5.12 % | -12.24 % |
Other Income | Rs. 2.007 Cr | Rs. 4.775 Cr | Rs. 2.818 Cr | -40.98 % | + 40.41 % |
Interest | Rs. 4.78 Cr | Rs. 3.39 Cr | Rs. 3.43 Cr | + 1.18 % | -28.24 % |
Depreciation | Rs. 5.95 Cr | Rs. 6.46 Cr | Rs. 6.12 Cr | -5.26 % | + 2.86 % |
Profit before tax | Rs. 2.21 Cr | Rs. 0.91 Cr | Rs. -5.93 Cr | -751.65 % | -368.33 % |
Tax % | 0 % | 885.92 % | -0 % | -885.92 % | 0 % |
Net Profit | Rs. 2.21 Cr | Rs. -7.14 Cr | Rs. -5.93 Cr | + 16.95 % | -368.33 % |
EPS in Rs | Rs. 0.64 | Rs. -2.41 | Rs. -2.01 | + 16.6 % | -414.06 % |
Today, we’re looking at FERMENTA BIOTECH LIMITED’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -5.23 %. However, it did see a marginal slip of -19.73 % from the previous quarter. Expenses decreased slightly by -15.36 % quarter-on-quarter, aligning with the annual rise of 8.12 %. Operating profit, while down -92.68 % compared to last year, faced a quarter-on-quarter dip of -86.62 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -12.24 %, but a shrinkage of -5.12 % sequentially. Other income fell by -40.98 % compared to the last quarter, despite an annual growth of 40.41 %. Interest expenses surged remarkably by 1.18 % from the previous quarter, yet the year-over-year decrease remains at a moderate -28.24 %. Depreciation costs fell by -5.26 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 2.86 %. Profit before tax declined annually by -368.33 % but saw a reduction from the preceding quarter by -751.65 %.
with a more notable quarter-on-quarter decrease of -885.92 %. Net profit fell by -368.33 % year-on-year but experienced a 16.95 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -414.06 % but a quarterly rise of 16.6 %. In summary, FERMENTA BIOTECH LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 82.448 Cr | Rs. 97.339 Cr | Rs. 78.132 Cr | -19.73 % | -5.23 % |
Expenses | Rs. 71.52 Cr | Rs. 91.36 Cr | Rs. 77.33 Cr | -15.36 % | + 8.12 % |
Operating Profit | Rs. 10.93 Cr | Rs. 5.98 Cr | Rs. 0.8 Cr | -86.62 % | -92.68 % |
Net Profit | Rs. 2.21 Cr | Rs. -7.14 Cr | Rs. -5.93 Cr | + 16.95 % | -368.33 % |
EPS in Rs | Rs. 0.64 | Rs. -2.41 | Rs. -2.01 | + 16.6 % | -414.06 % |
In reviewing FERMENTA BIOTECH LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -5.23 % year-on-year, although there was a slight dip of -19.73 % from the previous quarter. Expenses rose by 8.12 % compared to the previous year, with a decrease of -15.36 % quarter-on-quarter. Operating Profit dropped by -92.68 % annually, and saw a -86.62 % decrease from the last quarter.
Net Profit showed yearly decrease of -368.33 %, and experienced a 16.95 % increase from the previous quarter. Earnings Per Share (EPS) fell by -414.06 % annually, however rose by 16.6 % compared to the last quarter. In essence, while FERMENTA BIOTECH LIMITED faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1]